GOSS
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
P/B of -0.71 indicates the company is technically insolvent on a balance sheet basis.
- Negative Price/Book ratio
- No P/E or Graham Number available due to losses
Growth in revenue is irrelevant without a viable path to positive margins.
- Strong revenue growth (47%)
- Negative YoY EPS growth (-40%)
- Lack of a clear path to profitability
Long-term historical trend is overwhelmingly bearish.
- 5Y Change: -95.6%
- 6M Change: -85.5%
- Consistent earnings misses
The 0/9 F-Score is a definitive red flag for financial instability.
- Current Ratio > 2.0
- Piotroski F-Score: 0/9
- Negative equity
- Severe operating losses
Not a dividend-paying security.
- No dividend history
- Zero payout capacity
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for GOSS and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
GOSS
Gossamer Bio, Inc.
Primary
|
-95.6% | -66.2% | -57.8% | -85.5% | -26.7% | +0.4% |
|
BDSX
Biodesix, Inc.
Peer
|
-97.8% | -75.2% | -34.9% | +31.6% | +72.1% | +49.0% |
|
AMWL
American Well Corporation
Peer
|
-99.3% | -93.4% | -55.6% | -45.6% | +6.1% | +3.4% |
|
ASRT
Assertio Holdings, Inc.
Peer
|
-80.4% | -85.9% | -2.8% | -7.5% | -1.3% | -1.5% |
|
FORA
Forian Inc.
Peer
|
-82.8% | -35.5% | +13.5% | -7.0% | +2.9% | +1.9% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
GOSS
Gossamer Bio, Inc.
|
BEARISH | $87.21M | - | -% | -% | $0.37 | |
|
BDSX
Biodesix, Inc.
|
BEARISH | $93.92M | - | -302.6% | -49.3% | $11.74 | Compare |
|
AMWL
American Well Corporation
|
BEARISH | $79.73M | - | -37.0% | -42.8% | $4.87 | Compare |
|
ASRT
Assertio Holdings, Inc.
|
BEARISH | $74.82M | - | -24.5% | -21.1% | $11.66 | Compare |
|
FORA
Forian Inc.
|
BEARISH | $66.86M | - | -9.6% | -9.5% | $2.14 | Compare |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-02 | HASNAIN FAHEEM | Chief Executive Officer | Stock Award | 280,000 | - |
| 2026-01-02 | GIRAUDO BRYAN M. | Chief Operating Officer | Stock Award | 115,750 | - |
| 2026-01-02 | PETERSON CARYN | Officer | Stock Award | 84,500 | - |
| 2026-01-02 | ARANDA RICHARD | Officer | Stock Award | 93,750 | - |
| 2026-01-02 | CHRISTIAN WAAGE | Officer | Stock Award | 84,500 | - |
| 2026-01-02 | SMITH ROBERT PAUL JR | Officer | Stock Award | 93,750 | - |
Wall Street Analysts
Professional analyst ratings and price targets
Past News Coverage
Recent headlines mentioning GOSS from our newsroom.